Testing for BRCA1 and BRCA2 and one of the most common requests that we get. Because genetic information provides information that can help modify risks testing is often indicated for patients that have a strong likelihood of developing Breast and Ovarian Cancer. The American Society of Clinical Oncology recently released guidelines that support cancer risk assessment and prevention services for individuals who are suspected to be at high risk for developing breast and/or ovarian cancer.
Depending one your ethnic background, the lifetime risk for developing breast cancer is estimated around 12%. The lifetime risk for developing ovarian cancer is about 2%. There are genetic alterations that can be passed from parent to child that can increase the risk of breast and ovarian cancer substantially. Two genes identified to be associated with heridtary (inherited in families) breast and ovarian cancer are BRCA1 and BRCA2. The lifetime risk for developing cancer in patients with BRCA1 or BRCA2 mutations is:
Not every individual, even with genetic and familial risk factors will get cancer? We cannot predict if you will get cancer, we can only determine risk with the goal of taking steps both preventive and therapeutic for decreasing that risk.
Patients with BRCA1 and BRCA2 Mutations are more likely to develop Breast and Ovarian Cancer at a young age
The American Society of Clinical Oncology suggests you thorough risk assessment.
Click Here for our Comprehensive Breast and Ovarian Cancer Risk Survey
For most individuals, BRCA1 and BRCA2 testing should be considered: If your have a Family Member with:
BRCA1 and BRCA2 Genetic Testing Services
The Genetic Medicine Clinic offers hereditary cancer risk assessment both in-office and Online, genetic counseling and genetic testing